Doesn't appear to be. The protocol lists 4 primary outcomes:
- Feasibility (no data but conclusion is no)
- Suitability and acceptability of health economic measures (no data)
- Qualitative information about patients' views (no data)
- Information on the # of patients engaged and retained (?)
The spreadsheet only contains the secondary outcomes of the usual set of psychometric questionnaires. Aim was for 100 participants, only provided incomplete data for 44. It's also a comparison with "standard care" but we have no idea what that was, as usual not controlled for.
The "intervention" being a hodge-podge of the standard behavioral approach seems to indicate it serves no benefits to whatever this patient population is:
None of the data actually relate to any of this so basically the "intervention" and what is measured have about nothing to do with one another.
Looking at the protocol and noticed this interesting bit of... uh... "special" logic:
Another framing of the primary outcomes:
There is no data on adherence of follow-up rates beyond missing data but there are no details about why data are missing. There is supposed to be a 6 months qualitative study including GP interviews, no data on this.
Unclear whether the interviews even happened and, if not, why they did not happen.
There are various uses of generic fatigue, chronic fatigue and CFS. The data key defines this trial as being a CFS cohort:
But the criteria are clearly not a valid CFS cohort:
The health economics analysis seems to have been dropped. Seems similar in thinking to the one done for PACE.
I think most of the relevant details would be in the TMG notes, just like with PACE: